Melanomas in renal transplant recipients: a single-centre study

Skin cancers are the most common malignancies in renal transplantrecipients, with squamous-cell and basal-cell cancers accounting for the majorityof all skin cancer cases. Melanoma is relatively rare in this group of patients.From 1973 to May 2017, out of 1889 patients who received allografts at our institution,4 developed melanoma. After the mean follow-up of 11.5 months, 2patients died and 2 are still alive with functioning allografts. Malignancies werelocalized in the legs in both female patients, and in the neck and head in 1 malepatient each. Compared to the general population of Croatia, renal transplantrecipients from our cohort have 6.85 times higher risk for development of melanoma.Regular screenings and patient education are mandatory, especially inMediterranean countries.
Source: Acta Dermatovenerologica Croatica - Category: Dermatology Source Type: research